Effects of cyclosporin A on the activation of natural killer T cells induced by α-galactosylceramide

Transplantation

Volumn 83, Issue 2, 2007, Pages 184-192

  Kajiwara, Takashi ^a   Tomita, Yukihiro ^a   Okano, Shinji ^a   Iwai, Toshiro ^a   Yasunami, Youichi ^b   Yoshikai, Yasunobu ^c   Nomoto, Kikuo ^c   Yasui, Hisataka ^a   Tominaga, Ryuji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

galactosylceramide; Cyclosporin A; Natural killer T cells

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; BIOLOGICAL MARKER; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL SURFACE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; IMMUNOREGULATION; IMMUNOTHERAPY; KINETICS; LIVER; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE ACTIVATION; TRANSPLANTATION TOLERANCE; UPREGULATION;

ANIMALS; ANTIGENS, CD3; APOPTOSIS; CELL DIFFERENTIATION; CYCLOSPORINE; CYTOKINES; DENDRITIC CELLS; FEMALE; GALACTOSYLCERAMIDES; INJECTIONS, INTRAPERITONEAL; KINETICS; LIVER TRANSPLANTATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MICE; SPLEEN; T-LYMPHOCYTES, REGULATORY; THYMECTOMY; TIME FACTORS;

EID: 33846618657     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000250573.50046.89     Document Type: Article

References (45)

1. + subset. J Immunol 1990; 145: 1039.
2. + cells. J Immunol 1990; 145: 3209.
3. + thymocytes. J Immunol 1991; 146: 1113.
4. + thymocytes. J Immunol 1991; 146: 1134.
5. Kawano T, Cui J, Koezuka Y, et al. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997; 278: 1626.
6. Osman Y, Kawamura T, Naito T, et al. Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide. Eur J Immunol 2000; 30: 1919.
7. Hayakawa Y, Takeda K, Yagita H, et al. Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity, to anti-metastatic effect of α-galactosylceramide. Eur J Immunol 2001; 31: 1720.
8. Leite-de-Moraes MC, Herbelin A, Gouarin C, et al. Fas/Fas ligand interactions promote activation-induced cell death of NKT lymphocytes. J Immunol 2000; 165: 4367.
9. Eberl G, MacDonald HR. Rapid death and regeneration of NKT cells in anti-CD3e- or IL-12-treated mice: a major role for bone marrow in NKT cell homeostasis. Immunity 1998; 9: 345.
10. Wilson MT, Johansson C, Olivares-Villagomez D, et al. The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci USA 2003; 100: 10913.
11. Crowe NY, Uldrich AP, Kyparissoudis K, et al. Glycolipid antigen drives rapid expansion and sustained cytokine production by NKT cells. J Immunol 2003; 171: 4020.
12. Harada M, Seino K, Wakao H, et al. Down-regulation of the invariant Vα14 antigen receptor in NKT cells upon activation. Int Immunol 2004; 16: 241.
13. Hong S, Wilson MT, Serizawa I, et al. The natural killer T cell ligand α-galactosylceramide prevents autoimmune diabetes in non-obese diabetic mice. Nat Med 2001; 7: 1052.
14. Sharif S, Arreaza GA, Zucker P, et al. Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune type I diabetes. Nat Med 2001; 7: 1057.
15. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 2002; 99: 1259.
16. Nakagawa R, Nagafune I, Tazunoki Y, et al. Mechanism of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice. J Immunol 2001; 166: 6578.
17. + Vα14 natural killer T cells are essential for acceptance for rat islet xenografts in mice. J Clin Invest 2000; 105: 1761.
18. Seino K, Fukao K, Muramoto K, et al. Requirement for natural killer T (NKT) cells in the induction of allograft tolerance. Proc Natl Acad Sci USA 2001; 98: 2577.
19. Fukuzawa M, Shearer GM. Effect of cyclosporine A on T cell immunity. I. Dose-dependent suppression of different murine T helper cell pathways. Eur J Immunol 1989; 19: 49.
20. Sakaguchi S, Sakaguchi N. Organ-specific autoimmune disease induced in mice by elimination of T cell subsets. J Immunol 1989; 142: 471.
21. Bucy RP, Xu XY, Li J, et al. Cyclosporin A-induced autoimmune disease in mice. J Immunol 1993; 151: 1039.
22. Cheney RT, Sprent J. Capacity of cyclosporine to induce auto-graft-versus-host disease and impair intrathymic T cell differentiation. Transplant Proc 1985; 17: 528.
23. Hess AD, Fischer AC, Beschorner WE. Effector mechanisms in cyclosporine A-induced syngeneic graft-versus-host disease. J Immunol 1990; 145: 526.
24. Nomoto K, Eto M, Yanaga K, et al. Interference with cyclophosphamide- induced skin graft allograft tolerance by cyclosporine A. J Immunol 1992; 149: 2668.
25. Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J Immunol 1994; 153: 1087.
26. Eberl G, MacDonald HR. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 2000; 30: 985.
27. Fujii S, Shimizu K, Smith C, et al. Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 2003; 198: 267.
28. Kronenberg M. Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005; 26: 877.
29. Taniguchi M, Seino K, Nakayama T. The NKT cell system: bridging and acquired immunity. Nat Immunol 2003; 4: 1164.
30. Elliot JF, Lin Y, Mizel SB, et al. Induction of interleukin-2 messenger RNA inhibited by cyclosporine A. Science 1984; 226: 1439.
31. Kronke M, Leonard WJ, Depper JM, et al. Cyclosporin A inhibits T cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci USA 1984; 81: 5214.
32. Jenkins MK, Schwartz RH, Pardoll DM. Effects of cyclosporin A on T cell development and clonal deletion. Science 1988; 241: 1655.
33. Gao EK, Lo D, Cheney R, et al. Abnormal differentiation of thymocytes in mice treated with cyclosporine A. Nature 1988; 336: 176.
34. Shi Y, Sahai BM, Green DR. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes. Nature 1989; 339: 625.
35. Masuhara M, Ogasawara H, Katyal SL, et al. Cyclosporin stimulates hepatocyte proliferation and accelerates development of hepatocellular carcinomas in rats. Carcinogenesis 1993; 14: 1579.
36. Shimizu T, Martin MS, Pelletier H, et al. Effects of cyclosporin A on progressive and regressive tumors induced by two cancer lines derived from a single colon carcinoma chemically induced in the rat. Immunobiology 1989; 178: 401.
37. Zhang HG, Su X, Liu D, et al. Induction of specific T cell tolerance by fas ligand-expressing antigen-presenting cells. J Immunol 1999; 162: 1423.
38. George JF, Sweeney SD, Kirklin JK, et al. An essential role for fas ligand in transplantation tolerance induced by donor bone marrow. Nat Med 1998; 4: 333.
39. Blaha P, Bigenzahn S, Koporc ZM, et al. The influence of immunosuppressive drugs on tolerance induction through bone marrow transplantation with costimulation blockade. Blood 2003; 101: 2886.
40. Smith CR, Mohanakumar T, Shimizu Y, et al. Brief cyclosporin treatment prevents intrathymic (IT) tolerance induction and precipitates acute rejection in an IT rat cardiac allograft model. Transplantation 2000; 69: 294.
41. Gorczynski RM, Holmes W. Cyclosporin alters the induction of allospecific tolerance in vivo. Immunol Lett 1987; 15: 193.
42. Smith CA, Williams GT, Kingston R, et al. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature 1989; 337: 181.
43. Gapin L, Matsuda JL, Surn CD, et al. NKT cells derive from double-positive thymocytes that are positively selected by CD1d. Nat Immunol 2001; 2: 971.
44. Pellicci DG, Hammond KJL, Uldrich AP, et al. A natural killer T (NKT) cell development pathway involving a thymus-dependent precursor stage. J Exp Med 2002; 195: 835.
45. Benlagha K, Kyin T, Beavis A, et al. A thymic precursor to the NK T cell lineage. Science 2002; 296: 553.